About Granalix
Granalix is a Healthcare company based in Jerusalem (Israel) founded in 2013. Natural antioxidants are formulated for neurodegenerative disorder prevention and treatment. Its website granalix.com draws about 18 thousand monthly visits. Granalix offers products and services including GranaGard Nano-Omega 5. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is Granalix Bio Technologies Ltd.
Company details
Granalix Biotechnologies was founded in 2013 in Jerusalem, Israel, within the biotechnology sector. Operations center on creating formulations of natural compounds to improve bioavailability and enable targeting of specific organs, including the brain. The initial product, GranaGard, consists of a submicron self-emulsion of pomegranate seed oil that converts to conjugated linoleic acid in vivo. Clinical trials are underway, with animal studies indicating neuroprotection and mitochondrial modulation benefits.
- Headquarters Jerusalem, Israel
- SectorsHealthcare
- Website category Health · Nutrition Diets and Fitness
- Email••••••••
- Website granalix.com
- Social Facebook
- Legal Name Granalix Bio Technologies Ltd
Products & Services of Granalix
Granalix offers a comprehensive portfolio of products and services, including GranaGard Nano-Omega 5.
Patented nanotech formula using pomegranate seed oil for omega5 benefits.
Web traffic of Granalix
The website of Granalix (granalix.com) receives about 18.1K visits a month and ranks #1,033,313 among all websites worldwide, #3,209 in Nutrition Diets and Fitness.
- Monthly visits18.1K
▼ 29.1% vs previous month
- Unique visitors15.7K
per month
- Global rank#1,033,313
among all websites
- Category rank#3,209
Health · Nutrition Diets and Fitness
- Bounce rate62%
- Pages per visit2.1
- Average visit28 sec
- DevicesDesktop 9% · Mobile 91%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Granalix
Granalix was founded in 2013.
Granalix is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Granalix Biotechnologies was founded in 2013 in Jerusalem, Israel, within the biotechnology sector. Operations center on creating formulations of natural compounds to improve bioavailability and enable targeting of specific organs, including the brain. The initial product, GranaGard, consists of a submicron self-emulsion of pomegranate seed oil that converts to conjugated linoleic acid in vivo. Clinical trials are underway, with animal studies indicating neuroprotection and mitochondrial modulation benefits.
Granalix offers GranaGard Nano-Omega 5.
Granalix operates through Granalix Bio Technologies Ltd.